Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (878)
  2. Journal Article (577)
  3. Review (73)
  4. Research Letter (39)
  5. Editorial (30)
  6. Correspondence (26)
  7. Miscellaneous (19)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1432)
  2. Hematologic Malignancies, Division of (1089)
  3. MSK Grad Students (1031)
  4. Master of Science in Clinical and Translational Cancer Research (996)
  5. Center for Hematologic Malignancies (990)
  6. Survivorship Research (931)

More Groups

People
  1. Sergio Giralt (557)
  2. Miguel-Angel Perales (413)
  3. Michael Scordo (389)
  4. Gunjan Shah (345)
  5. Sean Devlin (334)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (119)
  2. 2024 (255)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (87)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. American Society of Hematology (373)
  2. Elsevier Inc. (343)
  3. American Society of Clinical Oncology (160)
  4. Nature Publishing Group (139)
  5. Springer (107)
  6. American Association for Cancer Research (68)

More Publishers

Results (1664)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of ChatGPT for management recommendations in advanced ovarian cancer
    Meeting Abstract

    Finch, L.; Broach, V.; Feinberg, J.; Roche, K. L.; Gardner, G.; Sonoda, Y.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Oncologic outcomes of minimally invasive surgery versus laparotomy for the treatment of 2009 FIGO stage II endometrial cancer
    Meeting Abstract

    Dagher, C.; Mueller, J.; Sonoda, Y.; Broach, V.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Patterns of recurrence and outcomes in vulvar extramammary Paget's disease
    Meeting Abstract

    Lam, C.; Broach, V.; Sonoda, Y.; Roche, K. L.; Chi, D.; Kim, S.; Jewell, E.; Gardner, G.; Mueller, J.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Evaluating the risks of pleural effusions and chest tube placement at the time of cytoreductive surgery for advanced ovarian cancer
    Meeting Abstract

    Kahn, R.; Tian, E.; Yeoshoua, E.; Zhou, Q.; Iasonos, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Zivanovic, O.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Oncologic and surgical outcomes of robotic-assisted versus conventional laparoscopy for the treatment of clinically uterineconfined high-grade endometrial carcinoma
    Meeting Abstract

    Dagher, C.; Sonoda, Y.; Roche, K. L.; Jewell, E.; Chi, D.; Gardner, G.; Mueller, J.; Broach, V.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Hypoalbuminemia alone is not a contraindication to primary cytoreductive surgery in advanced ovarian cancer
    Meeting Abstract

    Finch, L.; Dagher, C.; Finlan, M.; Kahn, R.; Yeoshoua, E.; Broach, V.; Roche, K. L.; Gardner, G.; Sonoda, Y.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and tumor mutational burden are associated with higher microbiome diversity in the reproductive tract
    Meeting Abstract

    Rubinstein, M.; Gradissimo, A.; Taur, Y.; Varice, N.; Roche, K. L.; Broach, V.; Leitao, M.; Sonoda, Y.; Weigelt, B.; Zivanovic, O.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Successful implementation of a goals-to-discharge patient checklist following surgery for gynecologic cancer
    Meeting Abstract

    Byrne, M.; Roche, K. L.; Chi, D.; Sonoda, Y.; Abu-Rustum, N.; Gardner, G.; Broach, V.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Updated safety and efficacy from a phase 1 study of RMC-6236, a RAS (ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Wolpin, B.; Hong, D.; Spira, A.; Starodub, A.; Park, W.; Sommerhalder, D.; Valerin, J.; Barve, M.; Punekar, S.; Pelster, M.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of olomorasib (LY3537982), a second-generation KRAS G12C inhibitor (G12Ci), in combination with pembrolizumab in patients with KRAS G12C-mutant advanced NSCLC
    Meeting Abstract

    Burns, T. F.; Dragnev, K.; Fujiwara, Y.; Murciano-Goroff, Y. R.; Lee, D. H.; Hollebecque, A.; Koyama, T.; Cassier, P.; Italiano, A.; Heist, R. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save